Rigel Pharmaceuticals (RIGL) Other Working Capital Changes (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Other Working Capital Changes of -$145000.0 for Q1 2026, down 114.01% year-over-year from $1.0 million in Q1 2025, and down 2.84% quarter-over-quarter from -$141000.0 in Q4 2025.
Rigel Pharmaceuticals (RIGL) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$145000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 114.01% year-over-year to -$145000.0; the TTM figure through Mar 2026 stood at -$456000.0 (down 189.24% YoY), while the FY2025 annual figure was $724000.0, up 204.62% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$145000.0, down from -$141000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $13.2 million in Q1 2025, with the low at -$6.6 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is $1.4 million (2024), against an average of $1.0 million.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes plunged 447.13% in 2023, then surged 716.07% in 2025.
- Rigel Pharmaceuticals' Other Working Capital Changes stood at -$174000.0 in 2022, then advanced by 6.9% to -$162000.0 in 2023, then declined by 11.73% to -$181000.0 in 2024, then rose by 22.1% to -$141000.0 in 2025, then retreated by 2.84% to -$145000.0 in 2026.
- Business Quant data shows RIGL's Other Working Capital Changes at -$145000.0 in Q1 2026, -$141000.0 in Q4 2025, and -$81000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.97 Mn |
| Jun 30, 2026 | -5.97 Mn |
| Jun 30, 2026 | -5.97 Mn |
| Mar 31, 2026 | 3.79 Mn |
| Mar 31, 2026 | 3.79 Mn |
| Mar 31, 2026 | 3.79 Mn |
| Dec 31, 2025 | 3.39 Mn |
| Dec 31, 2025 | 3.39 Mn |
| Dec 31, 2025 | 3.39 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | -6.56 Mn |
| Jun 30, 2025 | -6.56 Mn |
| Jun 30, 2025 | -6.56 Mn |
| Mar 31, 2025 | 13.15 Mn |
| Mar 31, 2025 | 13.15 Mn |
| Mar 31, 2025 | 13.15 Mn |
| Dec 31, 2024 | -44,000.00 |
| Dec 31, 2024 | -44,000.00 |